Diagnostic analysis indicated that DUXAP8, MEGEA1, MKRN3, and DGKI are potential diagnostic biomarkers of HCC while DUXAP8 and RNF2 are potential prognostic biomarkers of HCC. This evidence concerns the gene DGKI and hepatocellular carcinoma.